{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T03:07:07Z","timestamp":1782702427376,"version":"3.54.5"},"reference-count":71,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2016,2,27]]},"DOI":"10.3233\/jad-151013","type":"journal-article","created":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T11:06:50Z","timestamp":1456830410000},"page":"123-138","source":"Crossref","is-referenced-by-count":49,"title":["T3D-959: A Multi-Faceted Disease Remedial Drug Candidate for the Treatment of Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"51","author":[{"given":"Ming","family":"Tong","sequence":"first","affiliation":[{"name":"Liver Research Center, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Division of Gastroenterology, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Department of Medicine, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetram","family":"Deochand","sequence":"additional","affiliation":[{"name":"Liver Research Center, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Division of Gastroenterology, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Department of Medicine, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Didsbury","sequence":"additional","affiliation":[{"name":"T3D Therapeutics, Inc., Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M.","family":"de la Monte","sequence":"additional","affiliation":[{"name":"Liver Research Center, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Division of Gastroenterology, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Division of Neuropathology, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Department of Medicine, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"},{"name":"Department of Pathology, Rhode Island Hospital and the Warren Alpert Medical School of Brown University, Providence, RI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-151013_ref1","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u2019s disease is type 3 diabetes-evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.3233\/JAD-151013_ref2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3233\/JAD-2005-7107","article-title":"Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer\u2019s disease\u2013is this type 3 diabetes?","volume":"7","author":"Steen","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s007020050067","article-title":"Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis","volume":"105","author":"Hoyer","year":"1998","journal-title":"J Neural Transm"},{"key":"10.3233\/JAD-151013_ref4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0047-6374(80)90120-7","article-title":"Glycolytic enzymes from human autoptic brain cortex: Normal aged and demented cases","volume":"14","author":"Iwangoff","year":"1980","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-151013_ref5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0140-6736(80)90884-3","article-title":"Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer\u2019s disease","volume":"1","author":"Sims","year":"1980","journal-title":"Lancet"},{"key":"10.3233\/JAD-151013_ref6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1385\/JMN:16:1:41","article-title":"Correlation of the clinical severity of Alzheimer\u2019s disease with an aberration in mitochondrial DNA (mtDNA)","volume":"16","author":"Brown","year":"2001","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-151013_ref7","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1212\/WNL.36.10.1390","article-title":"Stability of metabolic and neuropsychological asymmetries in dementia of the Alzheimer type","volume":"36","author":"Grady","year":"1986","journal-title":"Neurology"},{"key":"10.3233\/JAD-151013_ref8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","article-title":"Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD","volume":"32","author":"Mosconi","year":"2005","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-151013_ref9","first-page":"250","article-title":"FDG- and amyloid-PET in Alzheimer\u2019s disease: Is the whole greater than the sum of the parts?","volume":"55","author":"Mosconi","year":"2011","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"10.3233\/JAD-151013_ref10","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3233\/JAD-2006-10113","article-title":"Therapeutic rescue of neurodegeneration in experimental type 3 diabetes: Relevance to Alzheimer\u2019s disease","volume":"10","author":"de la Monte","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3233\/JAD-2005-8304","article-title":"Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer\u2019s disease: Link to brain reductions in acetylcholine","volume":"8","author":"Rivera","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref12","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1172\/JCI59903","article-title":"Demonstrated brain insulin resistance in Alzheimer\u2019s disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline","volume":"122","author":"Talbot","year":"2012","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.3233\/JAD-151013_ref13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neurobiolaging.2005.08.021","article-title":"Insulin resistance syndrome and Alzheimer\u2019s disease: Age- and obesity-related effects on memory, amyloid, and inflammation","volume":"26","author":"Craft","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-151013_ref14","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/01.wad.0000213866.86934.7e","article-title":"Insulin resistance syndrome and Alzheimer disease: Pathophysiologic mechanisms and therapeutic implications","volume":"20","author":"Craft","year":"2006","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-151013_ref15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/156720507780362137","article-title":"Insulin resistance and Alzheimer\u2019s disease pathogenesis: Potential mechanisms and implications for treatment","volume":"4","author":"Craft","year":"2007","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-151013_ref16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3233\/JAD-2006-9102","article-title":"Intracerebral streptozotocin model of type 3 diabetes: Relevance to sporadic Alzheimer\u2019s disease","volume":"9","author":"Lester-Coll","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref17","doi-asserted-by":"crossref","first-page":"7084","DOI":"10.1523\/JNEUROSCI.23-18-07084.2003","article-title":"Insulin receptor substrate-2 deficiency impairs brain growth and promotes tau phosphorylation","volume":"23","author":"Schubert","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-151013_ref18","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1073\/pnas.0308724101","article-title":"Role for neuronal insulin resistance in neurodegenerative diseases","volume":"101","author":"Schubert","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-151013_ref19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/(SICI)1097-4695(19990615)39:4<536::AID-NEU7>3.0.CO;2-J","article-title":"Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I","volume":"39","author":"Ryu","year":"1999","journal-title":"J Neurobiol"},{"key":"10.3233\/JAD-151013_ref20","doi-asserted-by":"crossref","first-page":"31601","DOI":"10.1074\/jbc.M202932200","article-title":"Differential roles of insulin receptor substrates in the anti-apoptotic function of insulin-like growth factor-1 and insulin","volume":"277","author":"Tseng","year":"2002","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-151013_ref21","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1111\/j.1474-9726.2011.00724.x","article-title":"Insulin-activated Akt rescues Abeta oxidative stress-induced cell death by orchestrating molecular trafficking","volume":"10","author":"Picone","year":"2011","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-151013_ref22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.neuropharm.2011.01.033","article-title":"Peripheral insulin-sensitizer drug metformin ameliorates neuronal insulin resistance and Alzheimer\u2019s-like changes","volume":"60","author":"Gupta","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-151013_ref23","doi-asserted-by":"crossref","first-page":"18742","DOI":"10.1074\/jbc.M109.011015","article-title":"Insulin receptor dysfunction impairs cellular clearance of neurotoxic oligomeric abeta","volume":"284","author":"Zhao","year":"2009","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-151013_ref24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1212\/WNL.0b013e3181eee25f","article-title":"Insulin resistance is associated with the pathology of Alzheimer disease: The Hisayama study","volume":"75","author":"Matsuzaki","year":"2010","journal-title":"Neurology"},{"key":"10.3233\/JAD-151013_ref25","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bbadis.2008.10.014","article-title":"Insulin resistance and amyloidogenesis as common molecular foundation for type 2 diabetes and Alzheimer\u2019s disease","volume":"1792","author":"Zhao","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-151013_ref26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","article-title":"Insulin-resistant brain state: The culprit in sporadic Alzheimer\u2019s disease?","volume":"10","author":"Correia","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-151013_ref27","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1016\/j.jalz.2006.05.197","article-title":"O3-02-02: Expression of pIRS-1 (S312 and S616) is elevated in MCI and AD and correlates with cognitive impairment and neurofibrillary pathology","volume":"2","author":"Talbot","year":"2006","journal-title":"Alzheimer Dement"},{"key":"10.3233\/JAD-151013_ref28","first-page":"217","article-title":"Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: An experimental approach","author":"Salkovic-Petrisic","year":"2007","journal-title":"J Neural Transm Suppl"},{"key":"10.3233\/JAD-151013_ref29","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J"},{"key":"10.3233\/JAD-151013_ref30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5483\/BMBRep.2009.42.8.475","article-title":"Insulin resistance and Alzheimer\u2019s disease","volume":"42","author":"de la Monte","year":"2009","journal-title":"BMB Rep"},{"key":"10.3233\/JAD-151013_ref31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3233\/JAD-2009-1115","article-title":"Nitrosamine exposure causes insulin resistance diseases: Relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer\u2019s disease","volume":"17","author":"Tong","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref32","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.neurobiolaging.2008.04.002","article-title":"Defects in IGF-1 receptor, insulin receptor and IRS-1\/2 in Alzheimer\u2019s disease indicate possible resistance to IGF-1 and insulin signalling","volume":"31","author":"Moloney","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-151013_ref33","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3233\/JAD-2011-101392","article-title":"Dementia, diabetes, Alzheimer\u2019s disease, and insulin resistance in the brain: Progress, dilemmas, new opportunities, and a hypothesis to tackle intersecting epidemics","volume":"25","author":"Kuljis","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref34","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/path.2912","article-title":"Deficient brain insulin signalling pathway in Alzheimer\u2019s disease and diabetes","volume":"225","author":"Liu","year":"2011","journal-title":"J Pathol"},{"key":"10.3233\/JAD-151013_ref35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1471-4159.2004.02949.x","article-title":"Activation of Akt\/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer\u2019s disease pathology","volume":"93","author":"Griffin","year":"2005","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-151013_ref36","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: Suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-151013_ref37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-151013_ref38","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/j.neubiorev.2007.04.004","article-title":"Molecular connexions between dementia and diabetes","volume":"31","author":"Cole","year":"2007","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-151013_ref39","doi-asserted-by":"crossref","first-page":"438","DOI":"10.2174\/156720508785908919","article-title":"Insulin resistance and Alzheimer\u2019s disease: Molecular links & clinical implications","volume":"5","author":"Neumann","year":"2008","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-151013_ref40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrneurol.2010.130","article-title":"How does diabetes accelerate Alzheimer disease pathology?","volume":"6","author":"Sims-Robinson","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-151013_ref41","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1111\/j.1464-5491.2011.03464.x","article-title":"Insulin resistance and pathological brain ageing","volume":"28","author":"Cholerton","year":"2011","journal-title":"Diabet Med"},{"key":"10.3233\/JAD-151013_ref42","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.brainresrev.2007.09.001","article-title":"Common pathological processes in Alzheimer disease and type 2 diabetes: A review","volume":"56","author":"Li","year":"2007","journal-title":"Brain Res Rev"},{"key":"10.3233\/JAD-151013_ref43","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1212\/01.wnl.0000435561.00234.ee","article-title":"Higher glucose levels associated with lower memory and reduced hippocampal microstructure","volume":"81","author":"Kerti","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-151013_ref44","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.2337\/dc11-0308","article-title":"Association of metabolic dysregulation with volumetric brain magnetic resonance imaging and cognitive markers of subclinical brain aging in middle-aged adults: The Framingham Offspring Study","volume":"34","author":"Tan","year":"2011","journal-title":"Diabetes Care"},{"key":"10.3233\/JAD-151013_ref45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.2174\/156720512799015037","article-title":"Brain insulin resistance and deficiency as therapeutic targets in Alzheimer\u2019s disease","volume":"9","author":"de la Monte","year":"2012","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-151013_ref46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1046\/j.1365-201X.2003.01161.x","article-title":"Peroxisome proliferator-activated receptors (PPARS): Regulators of gene expression in heart and skeletal muscle","volume":"178","author":"Gilde","year":"2003","journal-title":"Acta Physiol Scand"},{"key":"10.3233\/JAD-151013_ref47","first-page":"345","article-title":"The PPARs and PXRs: Nuclear xenobiotic receptors that define novel hormone signaling pathways","volume":"54","author":"Kliewer","year":"1999","journal-title":"Recent Prog Horm Res"},{"key":"10.3233\/JAD-151013_ref48","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0005-2760(96)00066-5","article-title":"The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation","volume":"1302","author":"Schoonjans","year":"1996","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-151013_ref49","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1210\/en.2003-0288","article-title":"Minireview: Lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors","volume":"144","author":"Lee","year":"2003","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-151013_ref50","first-page":"219583","article-title":"Inflammatory mediators and insulin resistance in obesity: Role of nuclear receptor signaling in macrophages","volume":"2010","author":"Fuentes","year":"2010","journal-title":"Mediators Inflamn"},{"key":"10.3233\/JAD-151013_ref51","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nri2748","article-title":"Nuclear receptor transrepression pathways that regulate inflammation in macrophages and T cells","volume":"10","author":"Glass","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.3233\/JAD-151013_ref52","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3233\/JAD-2009-1098","article-title":"Mechanisms of nitrosamine-mediated neurodegeneration: Potential relevance to sporadic Alzheimer\u2019s disease","volume":"17","author":"de la Monte","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref53","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1523\/JNEUROSCI.23-15-06264.2003","article-title":"Peroxisome proliferator-activated receptor-alpha activation as a mechanism of preventive neuroprotection induced by chronic fenofibrate treatment","volume":"23","author":"Deplanque","year":"2003","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-151013_ref54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000072088","article-title":"Agonists of peroxisome-proliferator activated receptor-gamma reduce renal ischemia\/reperfusion injury","volume":"23","author":"Sivarajah","year":"2003","journal-title":"Am J Nephrol"},{"key":"10.3233\/JAD-151013_ref55","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2174\/156720509789207949","article-title":"A PPARdelta agonist reduces amyloid burden and brain inflammation in a transgenic mouse model of Alzheimer\u2019s disease","volume":"6","author":"Kalinin","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-151013_ref56","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00125-011-2401-4","article-title":"The peroxisome proliferator-activated receptor (PPAR) beta\/delta agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells","volume":"55","author":"Serrano-Marco","year":"2012","journal-title":"Diabetologia"},{"key":"10.3233\/JAD-151013_ref57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbr.2010.08.002","article-title":"Rosiglitazone reversal of Tg2576 cognitive deficits is independent of peripheral gluco-regulatory status","volume":"216","author":"Rodriguez-Rivera","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.3233\/JAD-151013_ref58","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3233\/JAD-2012-111661","article-title":"Long-term pioglitazone treatment improves learning and attenuates pathological markers in a mouse model of Alzheimer\u2019s disease","volume":"30","author":"Searcy","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref59","doi-asserted-by":"crossref","unstructured":"Didsbury J , T3D Therapeutics, Inc. Receives FDA IND Approval to Begin Phase 2 Clinical Study of T3D-959 in Alzheimer\u2019s Patients, PRWEB,(http:\/\/www.prweb.com\/pdfdownload\/12799240.pdf) Accessed 11\/21-2015.","DOI":"10.1016\/j.jalz.2015.08.148"},{"key":"10.3233\/JAD-151013_ref60","first-page":"1044-P","article-title":"DB959-101: A Phase 1 randomized, placebo-controlled, double-blind, escalating single-dose study to evaluate the safety, tolerability, pharmacokinetics, and food effect of DB959Na in healthy male and female volunteers","volume":"71","author":"Delmedico","year":"2011","journal-title":"American Diabetes Association 71st Scientific Sessions"},{"key":"10.3233\/JAD-151013_ref61","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1038\/nprot.2006.450","article-title":"Stereotaxic gene delivery in the rodent brain","volume":"1","author":"Cetin","year":"2006","journal-title":"Nat Protoc"},{"key":"10.3233\/JAD-151013_ref62","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1463-1326.2009.01087.x","article-title":"Effects of pioglitazone and rosiglitazone combined with metformin on body weight in people with diabetes","volume":"11","author":"Derosa","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.3233\/JAD-151013_ref63","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.2741\/e482","article-title":"Therapeutic targets of brain insulin resistance in sporadic Alzheimer\u2019s disease","volume":"4","author":"de la Monte","year":"2012","journal-title":"Front Biosci (Elite Ed)"},{"key":"10.3233\/JAD-151013_ref64","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2005-7106","article-title":"Review of insulin and insulin-like growth factor expression, signaling, and malfunction in the central nervous system: Relevance to Alzheimer\u2019s disease","volume":"7","author":"de la Monte","year":"2005","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-151013_ref65","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s12031-008-9041-2","article-title":"Insulin-like growth factor system regulates oligodendroglial cell behavior: Therapeutic potential in CNS","volume":"35","author":"Chesik","year":"2008","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-151013_ref66","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1471-4159.2008.05631.x","article-title":"IRS-2 branch of IGF-1 receptor signaling is essential for appropriate timing of myelination","volume":"107","author":"Freude","year":"2008","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-151013_ref67","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.mehy.2008.04.006","article-title":"In vivo insulin deficiency as a potential etiology for demyelinating disease","volume":"71","author":"Gong","year":"2008","journal-title":"Med Hypotheses"},{"key":"10.3233\/JAD-151013_ref68","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12640-012-9313-z","article-title":"Cholinergic dysfunctions and enhanced oxidative stress in the neurobehavioral toxicity of lambda-cyhalothrin in developing rats","volume":"22","author":"Ansari","year":"2012","journal-title":"Neurotox Res"},{"key":"10.3233\/JAD-151013_ref69","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.tiv.2010.09.010","article-title":"Fullerene antioxidants decrease organophosphate-induced acetylcholinesterase inhibition in vitro","volume":"25","author":"Ehrich","year":"2011","journal-title":"Toxicol In Vitro"},{"key":"10.3233\/JAD-151013_ref70","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuro.2012.01.008","article-title":"Monocrotophos induced oxidative damage associates with severe acetylcholinesterase inhibition in rat brain","volume":"33","author":"Kazi","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.3233\/JAD-151013_ref71","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/nan.12084","article-title":"Phosphorylation of tau protein at sites Ser(396-404) is one of the earliest events in Alzheimer\u2019s disease and Down syndrome","volume":"40","author":"Mondragon-Rodriguez","year":"2014","journal-title":"Neuropathol Appl Neurobiol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-151013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:02:16Z","timestamp":1777370536000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-151013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,27]]},"references-count":71,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-151013","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,27]]}}}